CR plus transcranial direct current stimulation slows cognitive decline in older adults with remitted MDD with or without MCI

Significant reduction seen in secondary outcome of long-term depression but not in medium-term depression

Highest rates seen during COVID-19 pandemic versus before pandemic and in females, those aged 14 to 17 and 18 to 22 years

Additionally, a higher prevalence of lifetime suicide plan and attempts was observed

Small, but significant effects seen at six months and sustained at 12 months

Findings seen for attention-deficit/hyperactivity disorder or depressive disorder

Estimated percentage eligible ranges from 24 to 62 percent depending on eligibility criteria used

No increase observed in diagnoses following onset of COVID-19, but increase seen in proportion of women filling benzodiazepine prescription

Patients with CRS have increased risk for developing common psychiatric disorders and vice versa